112295-37-1

Basic information

• Product Name: δ-benzyl N-(tert-butyloxycarbonyl)-DL-aminoadipate
• Synonyms: δ-benzyl N-(tert-butyloxycarbonyl)-DL-aminoadipate
• CAS NO: 112295-37-1
• Molecular Weight: 351.4
• Mol File: 112295-37-1.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: δ-benzyl N-(tert-butyloxycarbonyl)-DL-aminoadipate(CAS DataBase Reference)
• NIST Chemistry Reference: δ-benzyl N-(tert-butyloxycarbonyl)-DL-aminoadipate(112295-37-1)
• EPA Substance Registry System: δ-benzyl N-(tert-butyloxycarbonyl)-DL-aminoadipate(112295-37-1)

Safety Data

• Hazardous Substances Data: 112295-37-1(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 38658-15-0 (S)-2-amino-6-(benzyloxy)-6-oxohexanoic acid 
• 1118-90-7 L-homoglutamic acid 
• 100-51-6 benzyl alcohol 
• 108312-38-5 N^α,N^ε-di-tert-butyloxycarbonyl-L-lysine 2,2,2-trichloroethyl ester 
• 108312-35-2 N^α,N^ca-di-tert-butyloxycarbonyl-L-homoglutamine 
• 20194-18-7 sodium phenyl-methanolate 
• 58632-95-4 2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile 
• 542-32-5 (R,S)-2-aminoadipic acid 
• 80446-57-7 DL-α-aminoadipic acid γ-benzyl ester 

Downstream Products

• 124184-51-6 C₂₂H₂₈N₂O₈ 
• 171272-37-0 (3S)-3-{(2S)-5-benzyloxycarbonyl-2-(tert-butoxycarbonyl)aminopentanoyl}oxy-15-methylhexadecanamide 
• 171270-54-5 (3S)-3-[(2S)-5-benzyloxycarbonyl-2-(tertiarybutoxycarbonylamino)-pentanoyl]oxyhexadecanamide 
• 77302-98-8 (S)-2-[(S)-5-Benzyloxycarbonyl-2-((S)-5-benzyloxycarbonyl-2-tert-butoxycarbonylamino-pentanoylamino)-pentanoylamino]-4-methyl-pentanoic acid methyl ester 
• 77930-81-5 (6R,7R)-7-[5-tert-Butoxycarbonylamino-5-(2,2,2-trichloro-ethoxycarbonyl)-pentanoylamino]-3-carbamoyloxymethyl-7-methoxy-8-oxo-5-oxa-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester 
• 77930-80-4 (6R,7R)-3-Acetoxymethyl-7-[5-tert-butoxycarbonylamino-5-(2,2,2-trichloro-ethoxycarbonyl)-pentanoylamino]-7-methoxy-8-oxo-5-oxa-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester 
• 78005-11-5 (6R,7S)-3-Acetoxymethyl-7-[5-tert-butoxycarbonylamino-5-(2,2,2-trichloro-ethoxycarbonyl)-pentanoylamino]-8-oxo-5-oxa-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester 
• 77930-79-1 (6R,7R)-7-[5-tert-Butoxycarbonylamino-5-(2,2,2-trichloro-ethoxycarbonyl)-pentanoylamino]-7-methoxy-3-methyl-8-oxo-5-oxa-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester 
• 77930-86-0 (6R,7R)-7-(5-tert-Butoxycarbonylamino-5-carboxy-pentanoylamino)-3-carbamoyloxymethyl-7-methoxy-8-oxo-5-oxa-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester 
• 77930-78-0 (6R,7S)-7-[5-tert-Butoxycarbonylamino-5-(2,2,2-trichloro-ethoxycarbonyl)-pentanoylamino]-3-methyl-8-oxo-5-oxa-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester 
• 77930-83-7 (6R,7S)-3-Acetoxymethyl-7-(5-tert-butoxycarbonylamino-5-carboxy-pentanoylamino)-8-oxo-5-oxa-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester 
• 77930-85-9 (6R,7R)-3-Acetoxymethyl-7-(5-tert-butoxycarbonylamino-5-carboxy-pentanoylamino)-7-methoxy-8-oxo-5-oxa-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester 
• 77930-82-6 (6R,7S)-7-(5-tert-Butoxycarbonylamino-5-carboxy-pentanoylamino)-3-methyl-8-oxo-5-oxa-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester 
• 77930-84-8 (6R,7R)-7-(5-tert-Butoxycarbonylamino-5-carboxy-pentanoylamino)-7-methoxy-3-methyl-8-oxo-5-oxa-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester 

Relevant articles and documents

CASPASE INHIBITORS AND METHODS OF USE THEREOF

Provided herein are compounds of formula (I), compositions comprising the compounds and method of treating various diseases with the compounds and compositions.

Synthesis and biological evaluation of boron peptide analogues of Belactosin C as proteasome inhibitors

A series of boron peptides 11, 13, 15 and 17 were designed and synthesized as proteasome inhibitors based on the structure of Belactosin C. Matteson homologation was a key step in the synthesis of the boron peptides. Compounds 11a and 13 showed significant inhibition of 20S proteasome chymotrypsin-like (β5) activity (IC50 = 0.28 and 0.51 μM, respectively). Furthermore, like PS-341, compound 11a increased the G2/M cell distribution. A biparametric cytofluorimetric analysis with FITC-labeled annexin V and propidium iodide showed induction of apoptosis by compound 11a at >1 μM concentrations of compound.

PROPERTIES OF Nα,Nca-DI-TERT-BUTYLOXYCARBONYL-ω-CARBAMOYL-α-AMINO ACIDS AND DIRECT SYNTHESIS OF PROTECTED HOMOGLUTAMIC ACID DERIVATIVES

The protected carboxamide function of Nα,Nca-di-tert-butyloxy-carbonyl-ω-carbamoyl-α-amino acids worked well with nucleophilic reagents.Applying this novel reactivity, we developed an efficient synthetic route to Nα-tert-butyloxycarbonylhomoglutamic acid and its derivatives, including Nα-tert-butyloxycarbonylhomoglutamic acid δ-benzyl ester, from Nα,Nca-di-tert-butyloxycarbonylhomoglutamine.KEYWORDS - protected homoglutamic acid synthesis; Nca-tert-butyloxycarbonylated carboxamide; hydrolysis; selective deprotection; Nα-tert-butyloxycarbonylhomoglutamic acid δ-benzyl ester; Nα-tert-butyloxycarbonylhomoglutamic acid α-tert-butyl ester; Nα-tert-butyloxycarbonylhomoglutamine; optical purity